Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy

Endothelial progenitor cells (EPCs) contribute to endothelial regeneration and thereby protect against cardiovascular disease (CVD). Patients with manifest CVD have reduced EPC levels, but it is not clear if this also occurs in subjects at high CVD risk without manifest atherosclerotic disease. Ther...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal Jg. 29; H. 22; S. 2808
Hauptverfasser:	Westerweel, Peter E, Visseren, Frank L J, Hajer, Gideon R, Olijhoek, Jobien K, Hoefer, Imo E, de Bree, Petra, Rafii, Shahin, Doevendans, Pieter A, Verhaar, Marianne C
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England 01.11.2008
Schlagworte:	Anticholesteremic Agents - pharmacology Azetidines - pharmacology Cross-Over Studies Drug Therapy, Combination Endothelial Cells - cytology Endothelium, Vascular - drug effects Ezetimibe Humans Male Metabolic Syndrome - complications Metabolic Syndrome - drug therapy Middle Aged Obesity - complications Postprandial Period - physiology Simvastatin - pharmacology Stem Cells - drug effects Stem Cells - physiology
ISSN:	1522-9645, 1522-9645
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!